Check out the latest edition of our B-GREAT newsletter for updates about inherited cancers in the context of racial inequalities in healthcare. You can read the newsletter by visiting πhttps://bgreatinitiative.inheritedcancer.net/wp-content/uploads/BGREAT-December-2022-Newsletter.pdf Please feel free to share with family members, friends, and/or your healthcare providers.
Tag: NF1
Permanent link to this article: https://inheritedcancer.net/post30623/
ICARE Social Media Post May 2022
Breast Cancer Genes in Women of African Ancestry
ICARE Social Media Post May 2022
Breast Cancer Genes in Women of African Ancestry
A recent study in women of African ancestry confirmed genes previously identified to have associations with breast cancer risk (BRCA1, BRCA2, PALB2, ATM, TP53, NF1, and CHEK2) and provided new evidence of breast cancer risk for RAD51C and RAD51D, which was identified previously in European ancestry populations.Check out the full article at πhttps://pubmed.ncbi.nlm.nih.gov/35396981/Reference: DΓaz-Zabala, et …
Permanent link to this article: https://inheritedcancer.net/post51722/
Permanent link to this article: https://inheritedcancer.net/post82021/
Permanent link to this article: https://inheritedcancer.net/post81321/
Permanent link to this article: https://inheritedcancer.net/post51821/
ICARE Social Media Post August 2020
Pheochromocytoma and Paraganglioma Genetic Testing
ICARE Social Media Post August 2020
Pheochromocytoma and Paraganglioma Genetic Testing
More than 40% of patients with pheochromocytoma or paraganglioma, regardless of age and family history, carry an inherited gene mutation. Given that gene mutation carriers may benefit from gene-specific cancer screening, all individuals diagnosed with one of these tumors should seek genetic counseling to discuss genetic testing options. Genes that predispose to pheochromocytoma and paraganglioma …
Permanent link to this article: https://inheritedcancer.net/post82520/
ICARE Social Media Post July 2020
BRCA1/2 and Other Gene Carriers with Breast Cancer Donβt Always Receive Recommended Treatment
ICARE Social Media Post July 2020
BRCA1/2 and Other Gene Carriers with Breast Cancer Donβt Always Receive Recommended Treatment
BRCA1/2 and other gene mutation carriers with early stage breast cancer are not always receiving cancer treatment as recommended by national guidelines. Even though more and more people have been tested for hereditary cancer over the years, using this information accurately to guide treatment has not been as successful. These findings highlight the need for …
Permanent link to this article: https://inheritedcancer.net/post71020/